{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:40:45Z","timestamp":1784036445350,"version":"3.55.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>\n                    This study investigated the prevalence and antibiotic resistance of\n                    <jats:italic toggle=\"yes\">Ureaplasma<\/jats:italic>\n                    spp. and\n                    <jats:italic toggle=\"yes\">Mycoplasma hominis<\/jats:italic>\n                    isolated from asymptomatic individuals in Korea. Endocervical swabs from women and urine from men, from a total of 5,781 asymptomatic individuals, were analyzed using a Mycoplasma IST2 Kit. Of the 4,825 specimens tested from females, 486 (10.1%) were positive culture. In these positive specimens, 437 (9.1%) were positive only for\n                    <jats:italic toggle=\"yes\">Ureaplasma<\/jats:italic>\n                    spp., 17 (0.4%) were positive only for\n                    <jats:italic toggle=\"yes\">M. hominis<\/jats:italic>\n                    , and 32 (0.7%) were positive for both\n                    <jats:italic toggle=\"yes\">Ureaplasma<\/jats:italic>\n                    spp. and\n                    <jats:italic toggle=\"yes\">M. hominis<\/jats:italic>\n                    . In males, of the 956 tested specimens, only 4 (0.42%) were positive for\n                    <jats:italic toggle=\"yes\">Ureaplasma<\/jats:italic>\n                    spp. and no\n                    <jats:italic toggle=\"yes\">M. hominis<\/jats:italic>\n                    colonization was identified. In antimicrobial susceptibility tests, more than 93.2% of both\n                    <jats:italic toggle=\"yes\">M. hominis<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">Ureaplasma<\/jats:italic>\n                    spp. was susceptible to tetracycline, doxycycline, josamycin, and pristinamycin. However,\n                    <jats:italic toggle=\"yes\">M. hominis<\/jats:italic>\n                    isolates were found to be highly resistant to erythromycin, azithromycin, and clarithromycin (82.4%, 70.6%, and 76.5%, respectively). Ofloxacin and ciprofloxacin, which have recently exhibited increasing resistance rates, showed rates of 17.7% and 35.3%, respectively, in\n                    <jats:italic toggle=\"yes\">M. hominis<\/jats:italic>\n                    , and 50.6% and 27.4%, respectively, in\n                    <jats:italic toggle=\"yes\">Ureaplasma<\/jats:italic>\n                    spp. In conclusion, accurate antimicrobial susceptibility tests of the genital mycoplasmas should be conducted for each case to select the appropriate antibiotics. Fluoroquinolone-based drugs should be avoided in the initial treatment of urogenital mycoplasmas because of the increasing rate of resistance to quinolones, although the susceptibility to tetracycline remains high in Korea.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2017.0431","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T16:27:52Z","timestamp":1525105672000},"page":"1391-1396","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence and Antimicrobial Susceptibility of\n                    <i>Ureaplasma<\/i>\n                    spp. and\n                    <i>Mycoplasma hominis<\/i>\n                    in Asymptomatic Individuals in Korea"],"prefix":"10.1177","volume":"24","author":[{"given":"Jin Bong","family":"Choi","sequence":"first","affiliation":[{"name":"The Catholic University of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ju","family":"Lee","sequence":"additional","affiliation":[{"name":"The Catholic University of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Kyung","family":"Lee","sequence":"additional","affiliation":[{"name":"Chung-Ang University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jong","family":"Lee","sequence":"additional","affiliation":[{"name":"The Catholic University of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Choon","family":"Park","sequence":"additional","affiliation":[{"name":"The Catholic University of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Youn","family":"Kim","sequence":"additional","affiliation":[{"name":"The Catholic University of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Sup","family":"Lee","sequence":"additional","affiliation":[{"name":"The Catholic University of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Sop","family":"Choe","sequence":"additional","affiliation":[{"name":"The Catholic University of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/9781555817381.ch62","volume-title":"Manual of clinical microbiology","author":"Waites K.B.","year":"2015","unstructured":"Waites K.B., , and Taylor-Robinson D.. 2015. Mycoplasma and Ureaplasma. In Jorgensen J.H., , Pfaller M.A., , and Carroll K.C. (eds.), Manual of clinical microbiology. 11th ed. ASM Press, Washington, DC, pp. 1088\u20131105.","edition":"11"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jac\/dkn158","article-title":"Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece","volume":"62","author":"Kechagia N.","year":"2008","unstructured":"Kechagia N., , Bersimis S., , and Chatzipanagiotou S.. 2008. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J. Antimicrob. Chemother., 62:122\u2013125.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-010-0136-x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00276.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2007.01.011"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02766.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113771"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02842.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/AAC.47.10.3323-3325.2003","article-title":"DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones","volume":"47","author":"Bebear C.M.","year":"2003","unstructured":"Bebear C.M., , Renaudin H., , Charron A., , Clerc M., , Pereyre S., , and Bebear C.. 2003. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob. Agents Chemother., 47:3323\u20133325.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1128\/AAC.45.9.2604-2608.2001","article-title":"Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones","volume":"45","author":"Kenny G.E.","year":"2001","unstructured":"Kenny G.E., , and Cartwright F.D.. 2001. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob. Agents Chemother., 45:2604\u20132608.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/AAC.47.1.161-165.2003","article-title":"In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas","volume":"47","author":"Waites K.B.","year":"2003","unstructured":"Waites K.B., , Crabb D.M., , Bing X., , and Duffy L.B.. 2003. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother., 47:161\u2013165.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/clinids\/17.Supplement_1.S200","article-title":"Susceptibility of mycoplasmas to antimicrobial agents: clinical implications","volume":"1","author":"McCormack W.M.","year":"1993","unstructured":"McCormack W.M. 1993. Susceptibility of mycoplasmas to antimicrobial agents: clinical implications. Clin. Infect. Dis. 17 Suppl, 1:S200\u2013S201.","journal-title":"Clin. Infect. Dis. 17 Suppl"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.5.622"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1574-6968.1992.tb05379.x","article-title":"Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline","volume":"74","author":"Blanchard A.","year":"1992","unstructured":"Blanchard A., , Crabb D.M., , Dybvig K., , Duffy L.B., , and Cassell G.H.. 1992. Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline. FEMS Microbiol. Lett., 74:277\u2013281.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0378-6323.172903","article-title":"Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital","volume":"82","author":"Skiljevic D.","year":"2016","unstructured":"Skiljevic D., , Mirkov D., , and Vukicevic J.. 2016. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital. Indian J. Dermatol. Venereol. Leprol., 82:37\u201341.","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.4.757-789.2005"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1097-2765(01)00238-6","article-title":"Localization of the ribosomal protection protein Tet(O) on the ribosome and the mechanism of tetracycline resistance","volume":"7","author":"Spahn C.M.","year":"2001","unstructured":"Spahn C.M., , Blaha G., , Agrawal R.K., , Penczek P., , Grassucci R.A., , Trieber C.A., , Connell S.R., , Taylor D.E., , Nierhaus K.H., , and Frank J.. 2001. Localization of the ribosomal protection protein Tet(O) on the ribosome and the mechanism of tetracycline resistance. Mol. Cell, 7:1037\u20131045.","journal-title":"Mol. Cell"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1128\/AAC.01349-08","article-title":"Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance","volume":"53","author":"Beeton M.L.","year":"2009","unstructured":"Beeton M.L., , Chalker V.J., , Maxwell N.C., , Kotecha S., , and Spiller O.B.. 2009. Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance. Antimicrob. Agents Chemother., 53:2020\u20132027.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_20_2","first-page":"330","volume":"72","author":"Beeton M.L.","year":"2017","unstructured":"Beeton M.L., , and Spiller O.B.. 2017. Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? J. Antimicrob. Chemother., 72:330\u2013337.","journal-title":"Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? J. Antimicrob. Chemother."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10156-012-0527-z","article-title":"Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years","volume":"19","author":"De Francesco M.A.","year":"2013","unstructured":"De Francesco M.A., , Caracciolo S., , Bonfanti C., , and Manca N.. 2013. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J. Infect. Chemother., 19:621\u2013627.","journal-title":"J. Infect. Chemother."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2011.52.10.703"},{"key":"e_1_3_2_23_2","first-page":"79","article-title":"Prevalence and antimicrobial susceptibility of Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum in individuals with or without symptoms of genitourinary infections","volume":"6","author":"Kweon O.J.","year":"2016","unstructured":"Kweon O.J., , Lim Y.K., , Oh S.M., , Kim T.-H., , Choe H.-S., , Lee S.-J., , Cho Y.-H., , and Lee M.-K.. 2016. Prevalence and antimicrobial susceptibility of Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum in individuals with or without symptoms of genitourinary infections. Lab. Med. Online 6:79\u201387.","journal-title":"Lab. Med."},{"key":"e_1_3_2_24_2","first-page":"263","article-title":"Hormonal status and Mycoplasma colonization in the female genital tract","volume":"68","author":"Iwasaka T.","year":"1986","unstructured":"Iwasaka T., , Wada T., , Kidera Y., , and Sugimori H.. 1986. Hormonal status and Mycoplasma colonization in the female genital tract. Obstet. Gynecol., 68:263\u2013266.","journal-title":"Obstet. Gynecol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/JCM.44.1.51-55.2006","article-title":"Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy","volume":"44","author":"Kataoka S.","year":"2006","unstructured":"Kataoka S., , Yamada T., , Chou K., , Nishida R., , Morikawa M., , Minami M., , Yamada H., , Sakuragi N., , and Minakami H.. 2006. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J. Clin. Microbiol., 44:51\u201355.","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.3.1175-1179.2000"},{"key":"e_1_3_2_27_2","first-page":"34","article-title":"Prevalence of Chlamydia trachomatis and genital mycoplasmas in asymptomatic women","volume":"133","author":"Embil J.A.","year":"1985","unstructured":"Embil J.A., , and Pereira L.H.. 1985. Prevalence of Chlamydia trachomatis and genital mycoplasmas in asymptomatic women. Can. Med. Assoc. J., 133:34\u201335.","journal-title":"Can. Med. Assoc. J."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM198005083021905","article-title":"The genital mycoplasmas (second of two parts)","volume":"302","author":"Taylor-Robinson D.","year":"1980","unstructured":"Taylor-Robinson D., , and McCormack W.M.. 1980. The genital mycoplasmas (second of two parts). N. Engl. J. Med., 302:1063\u20131067.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJM198005013021805","article-title":"The genital mycoplasmas (first of two parts)","volume":"302","author":"Taylor-Robinson D.","year":"1980","unstructured":"Taylor-Robinson D., , and McCormack W.M.. 1980. The genital mycoplasmas (first of two parts). N. Engl. J. Med., 302:1003\u20131010.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12013-013-9691-8","article-title":"The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens","volume":"68","author":"Ye G.","year":"2014","unstructured":"Ye G., , Jiang Z., , Wang M., , Huang J., , Jin G., , and Lu S.. 2014. The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens. Cell Biochem. Biophys., 68:207\u2013210.","journal-title":"Cell Biochem. Biophys."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jmii.2014.06.007","article-title":"Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009\u20132013","volume":"49","author":"Wang Q.Y.","year":"2016","unstructured":"Wang Q.Y., , Li R.H., , Zheng L.Q., , and Shang X.H.. 2016. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009\u20132013. J. Microbiol. Immunol. Infect., 49:359\u2013362.","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.03.020"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3855\/jidc.8039","article-title":"Comparison of mycoplasma IES, mycofast revolution and mycoplasma IST2 to detect genital mycoplasmas in clinical samples","volume":"11","author":"D'Inzeo T.","year":"2017","unstructured":"D'Inzeo T., , De Angelis G., , Fiori B., , Menchinelli G., , Liotti F.M., , Morandotti G.A., , De Maio F., , Nagel D., , Antonaci M., , Sanguinetti M., , and Spanu T.. 2017. Comparison of mycoplasma IES, mycofast revolution and mycoplasma IST2 to detect genital mycoplasmas in clinical samples. J. Infect. Dev. Ctries., 11:98\u2013101.","journal-title":"J. Infect. Dev. Ctries."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462413515196"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3349\/ymj.2016.57.5.1271","article-title":"Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women","volume":"57","author":"Lee M.Y.","year":"2016","unstructured":"Lee M.Y., , Kim M.H., , Lee W.I., , Kang S.Y., , and Jeon Y.L.. 2016. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Yonsei Med. J., 57:1271\u20131275.","journal-title":"Yonsei Med. J."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.11.010"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2017.0431","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2017.0431","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2017.0431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:32:58Z","timestamp":1777667578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2017.0431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1089\/mdr.2017.0431"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2017.0431","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}